Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine

Immunology Letters

Volumn 92, Issue 3, 2004, Pages 237-243

  Zhu, Min Sheng ^a   Pan, Ying ^a   Chen, Hua Qun ^b   Shen, Yue ^a   Wang, Xiao Chun ^a   Sun, Yong Jun ^a   Tao, Kai Hua ^a  

^a HUADONG RESEARCH INSTITUTE FOR MEDICINE AND BIOTECHNICS   (China)

^b NANJING NORMAL UNIVERSITY   (China)

Author keywords

DNA Vaccination; Nucleocapsid; SARS

Indexed keywords

DNA VACCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; POLYCLONAL ANTIBODY; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ESCHERICHIA COLI; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VIRUS INDUCTION; VIRUS NUCLEOCAPSID;

ANIMALS; ANTIBODIES; FEMALE; MICE; NUCLEOPROTEINS; RABBITS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL PROTEINS;

EID: 1842664185     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.01.001     Document Type: Article

References (20)

1. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S.et al. The Genome sequence of the SARS-associated coronavirus. Science. 300:2003;1399-1404.
2. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P.et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300:2003;1394-1399.
3. Ruan Y.J., Wei C.L., Ee A.L., Vega V.B., Thoreau H., Su S.T.et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet. 361:2003;1779-1785.
4. Wilson J.A., Hart M.K. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein. J. Virol. 75:2001;2660-2664.
5. Vanderzanden L., Bray M., Fuller D., Roberts T., Custer D., Spik K.et al. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology. 246:1998;134-144.
6. Schadeck E.B., Partidos C.D., Fooks A.R., Obeid O.E., Wilkinson G.W., Stephenson J.R.et al. CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice. Virus Res. 65:1999;75-86.
7. Probst H.C., Tschannen K., Gallimore A., Martinic M., Basler M., Dumrese T.et al. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171:2003;5415-5422.
8. Ulmer J.B., Fu T.M., Deck R.R., Friedman A., Guan L., DeWitt C.et al. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 72:1998;5648-5653.
9. Fomsgaard A., Nielsen H.V., Kirkby N., Bryder K., Corbet S., Nielsen C.et al. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes. Vaccine. 18:1999;681-691.
10. Anton I.M., Gonzalez S., Bullido M.J., Corsin M., Risco C., Langeveld J.P.et al. Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies. Virus Res. 46:1996;111-124.
11. Li G., Chen X., Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349:2003;508-509.
12. Xu G., Lu H., Li J., Li Y., Feng Z.et al. Primary investigation on the changing mode of plasma specific IgG antibody in SARS patients and their physicians and nurses. Beijing Da Xue Xue Bao. 35(Suppl.):2003;23-25.
13. Che X.Y., Hao W., Qiu L.W., Pan Y.X., Liao Z.Y., Xu H.et al. Antibody response of patients with severe acute respiratory syndrome (SARS) to nucleocapsid antigen of SARS-associated coronavirus. Di Yi Jun Yi Da Xue Xue Bao. 23:2003;637-639.
14. Yu X.Y., Zhang Y.C., Han C.W., Wang P., Xue X.J., Cong Y.L. Change of T lymphocyte and its activated subsets in SARS patients. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 25:2003;542-546.
15. Wang J., Wen J., Li J., Yin J., Zhu Q., Wang H.et al. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin. Chem. 49:2003;1989-1996.
16. Hager D.A., Burgess R.R. Elution of protein from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of RNA polymerase, wheat germ DNA topoisomerase and other enzymes. Anal. Biochem. 109:1980;76-86.
17. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
18. Lin Y.L., Chen L.K., Liao C.L., Yeh C.T., Ma S.H., Chen J.L.et al. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 72:1998;191-200.
19. Gao W., Tamin A., Soloff A., D'Aiuto L., Nwanegbo E., Robbins P.D.et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet. 362:2003;1895-1896.
20. Li G., Chen X., Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349:2003;508-509.